About
Stem Cell-Modulating Therapeutics
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalStem Cell & Cellular TherapySan Diego & Southern California
Clinical Trials (23)
View allTotal Trials
23
As Lead Sponsor
23
As Collaborator
0
Total Enrollment
1,345
By Phase
PHASE1: 19PHASE1/PHASE2: 1PHASE2: 1
By Status
TERMINATED: 11COMPLETED: 6RECRUITING: 3ACTIVE_NOT_RECRUITING: 2WITHDRAWN: 1
Clinical Trials Pipeline23 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
Today
Hover over trial bars to see details
Recent Trials
NCT07216105Lead Sponsor
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
PHASE1Recruiting
113 participants
Started: Oct 30, 2025 · Completed: Jan 31, 2030
NCT06308978Lead Sponsor
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
PHASE1Recruiting
244 participants
Started: Mar 28, 2024 · Completed: Sep 30, 2042
NCT06241456Lead Sponsor
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
PHASE1Recruiting
351 participants
Started: Jan 5, 2024 · Completed: May 1, 2044
NCT05950334Lead Sponsor
FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)
PHASE1Completed
20 participants
Started: Nov 16, 2023 · Completed: Jun 30, 2025
NCT05934097Lead Sponsor
FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma
PHASE1Withdrawn
Started: Dec 31, 2022 · Completed: May 31, 2039
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...